nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE2—bile—liver cancer	0.198	0.578	CbGeAlD
Lisinopril—ACE2—gall bladder—liver cancer	0.0549	0.16	CbGeAlD
Lisinopril—ACE—umbilical vein—liver cancer	0.0437	0.128	CbGeAlD
Lisinopril—ACE2—liver—liver cancer	0.0161	0.047	CbGeAlD
Lisinopril—ACE—embryo—liver cancer	0.0114	0.0332	CbGeAlD
Lisinopril—SLC15A1—liver—liver cancer	0.00734	0.0214	CbGeAlD
Lisinopril—ACE—liver—liver cancer	0.00527	0.0154	CbGeAlD
Lisinopril—ABCB1—embryo—liver cancer	0.00401	0.0117	CbGeAlD
Lisinopril—Benazepril—MTHFR—liver cancer	0.00375	0.587	CrCbGaD
Lisinopril—Nateglinide—PPARG—liver cancer	0.00192	0.3	CrCbGaD
Lisinopril—ABCB1—liver—liver cancer	0.00185	0.00541	CbGeAlD
Lisinopril—Renal failure acute—Doxorubicin—liver cancer	0.00135	0.00207	CcSEcCtD
Lisinopril—Osteoarthritis—Epirubicin—liver cancer	0.00134	0.00206	CcSEcCtD
Lisinopril—Pain in extremity—Epirubicin—liver cancer	0.00134	0.00206	CcSEcCtD
Lisinopril—Diplopia—Epirubicin—liver cancer	0.00134	0.00206	CcSEcCtD
Lisinopril—Hypersensitivity—Sorafenib—liver cancer	0.00132	0.00202	CcSEcCtD
Lisinopril—Renal impairment—Doxorubicin—liver cancer	0.00131	0.002	CcSEcCtD
Lisinopril—Face oedema—Epirubicin—liver cancer	0.0013	0.00199	CcSEcCtD
Lisinopril—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00128	0.00197	CcSEcCtD
Lisinopril—Asthenia—Sorafenib—liver cancer	0.00128	0.00197	CcSEcCtD
Lisinopril—Cardiac arrest—Epirubicin—liver cancer	0.00128	0.00196	CcSEcCtD
Lisinopril—Hypoglycaemia—Doxorubicin—liver cancer	0.00127	0.00195	CcSEcCtD
Lisinopril—Cerebrovascular accident—Doxorubicin—liver cancer	0.00127	0.00195	CcSEcCtD
Lisinopril—Pruritus—Sorafenib—liver cancer	0.00126	0.00194	CcSEcCtD
Lisinopril—Ataxia—Epirubicin—liver cancer	0.00126	0.00194	CcSEcCtD
Lisinopril—Blood creatinine increased—Epirubicin—liver cancer	0.00126	0.00193	CcSEcCtD
Lisinopril—Dehydration—Epirubicin—liver cancer	0.00125	0.00192	CcSEcCtD
Lisinopril—Hyponatraemia—Doxorubicin—liver cancer	0.00125	0.00192	CcSEcCtD
Lisinopril—Osteoarthritis—Doxorubicin—liver cancer	0.00124	0.00191	CcSEcCtD
Lisinopril—Diplopia—Doxorubicin—liver cancer	0.00124	0.00191	CcSEcCtD
Lisinopril—Pain in extremity—Doxorubicin—liver cancer	0.00124	0.00191	CcSEcCtD
Lisinopril—Orthostatic hypotension—Epirubicin—liver cancer	0.00123	0.00188	CcSEcCtD
Lisinopril—Diarrhoea—Sorafenib—liver cancer	0.00122	0.00188	CcSEcCtD
Lisinopril—Breast disorder—Epirubicin—liver cancer	0.00121	0.00186	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00121	0.00186	CcSEcCtD
Lisinopril—Nasopharyngitis—Epirubicin—liver cancer	0.0012	0.00184	CcSEcCtD
Lisinopril—Face oedema—Doxorubicin—liver cancer	0.0012	0.00184	CcSEcCtD
Lisinopril—Gastritis—Epirubicin—liver cancer	0.00119	0.00182	CcSEcCtD
Lisinopril—Cardiac arrest—Doxorubicin—liver cancer	0.00118	0.00181	CcSEcCtD
Lisinopril—Dizziness—Sorafenib—liver cancer	0.00118	0.00181	CcSEcCtD
Lisinopril—Ataxia—Doxorubicin—liver cancer	0.00117	0.00179	CcSEcCtD
Lisinopril—Blood creatinine increased—Doxorubicin—liver cancer	0.00116	0.00179	CcSEcCtD
Lisinopril—Asthma—Epirubicin—liver cancer	0.00116	0.00178	CcSEcCtD
Lisinopril—Influenza—Epirubicin—liver cancer	0.00116	0.00178	CcSEcCtD
Lisinopril—Dehydration—Doxorubicin—liver cancer	0.00116	0.00177	CcSEcCtD
Lisinopril—Eosinophilia—Epirubicin—liver cancer	0.00115	0.00176	CcSEcCtD
Lisinopril—Pancreatitis—Epirubicin—liver cancer	0.00114	0.00175	CcSEcCtD
Lisinopril—Vomiting—Sorafenib—liver cancer	0.00114	0.00174	CcSEcCtD
Lisinopril—Orthostatic hypotension—Doxorubicin—liver cancer	0.00113	0.00174	CcSEcCtD
Lisinopril—Angina pectoris—Epirubicin—liver cancer	0.00113	0.00174	CcSEcCtD
Lisinopril—Rash—Sorafenib—liver cancer	0.00113	0.00173	CcSEcCtD
Lisinopril—Dermatitis—Sorafenib—liver cancer	0.00112	0.00173	CcSEcCtD
Lisinopril—Breast disorder—Doxorubicin—liver cancer	0.00112	0.00172	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00112	0.00172	CcSEcCtD
Lisinopril—Headache—Sorafenib—liver cancer	0.00112	0.00172	CcSEcCtD
Lisinopril—Bronchitis—Epirubicin—liver cancer	0.00112	0.00171	CcSEcCtD
Lisinopril—Nasopharyngitis—Doxorubicin—liver cancer	0.00111	0.00171	CcSEcCtD
Lisinopril—Pancytopenia—Epirubicin—liver cancer	0.0011	0.00169	CcSEcCtD
Lisinopril—Gastritis—Doxorubicin—liver cancer	0.0011	0.00169	CcSEcCtD
Lisinopril—Dysuria—Epirubicin—liver cancer	0.00109	0.00167	CcSEcCtD
Lisinopril—Neutropenia—Epirubicin—liver cancer	0.00109	0.00167	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Epirubicin—liver cancer	0.00108	0.00166	CcSEcCtD
Lisinopril—Asthma—Doxorubicin—liver cancer	0.00107	0.00165	CcSEcCtD
Lisinopril—Influenza—Doxorubicin—liver cancer	0.00107	0.00165	CcSEcCtD
Lisinopril—Eosinophilia—Doxorubicin—liver cancer	0.00106	0.00163	CcSEcCtD
Lisinopril—Nausea—Sorafenib—liver cancer	0.00106	0.00163	CcSEcCtD
Lisinopril—Photosensitivity reaction—Epirubicin—liver cancer	0.00106	0.00163	CcSEcCtD
Lisinopril—Weight increased—Epirubicin—liver cancer	0.00106	0.00162	CcSEcCtD
Lisinopril—Pancreatitis—Doxorubicin—liver cancer	0.00105	0.00162	CcSEcCtD
Lisinopril—Weight decreased—Epirubicin—liver cancer	0.00105	0.00161	CcSEcCtD
Lisinopril—Hyperglycaemia—Epirubicin—liver cancer	0.00105	0.00161	CcSEcCtD
Lisinopril—Angina pectoris—Doxorubicin—liver cancer	0.00105	0.00161	CcSEcCtD
Lisinopril—Pneumonia—Epirubicin—liver cancer	0.00104	0.0016	CcSEcCtD
Lisinopril—Bronchitis—Doxorubicin—liver cancer	0.00103	0.00159	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00103	0.00158	CcSEcCtD
Lisinopril—Pancytopenia—Doxorubicin—liver cancer	0.00102	0.00157	CcSEcCtD
Lisinopril—Renal failure—Epirubicin—liver cancer	0.00102	0.00156	CcSEcCtD
Lisinopril—Neuropathy peripheral—Epirubicin—liver cancer	0.00101	0.00156	CcSEcCtD
Lisinopril—Jaundice—Epirubicin—liver cancer	0.00101	0.00155	CcSEcCtD
Lisinopril—Urinary tract infection—Epirubicin—liver cancer	0.00101	0.00154	CcSEcCtD
Lisinopril—Dysuria—Doxorubicin—liver cancer	0.001	0.00154	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—liver cancer	0.001	0.00154	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000998	0.00153	CcSEcCtD
Lisinopril—Sweating—Epirubicin—liver cancer	0.000992	0.00152	CcSEcCtD
Lisinopril—Haematuria—Epirubicin—liver cancer	0.000987	0.00151	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—liver cancer	0.00098	0.00151	CcSEcCtD
Lisinopril—Hepatobiliary disease—Epirubicin—liver cancer	0.000979	0.0015	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—liver cancer	0.000977	0.0015	CcSEcCtD
Lisinopril—Epistaxis—Epirubicin—liver cancer	0.000976	0.0015	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—liver cancer	0.000971	0.00149	CcSEcCtD
Lisinopril—Sinusitis—Epirubicin—liver cancer	0.000971	0.00149	CcSEcCtD
Lisinopril—Hyperglycaemia—Doxorubicin—liver cancer	0.000969	0.00149	CcSEcCtD
Lisinopril—Agranulocytosis—Epirubicin—liver cancer	0.000966	0.00148	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—liver cancer	0.000963	0.00148	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000949	0.00146	CcSEcCtD
Lisinopril—Bradycardia—Epirubicin—liver cancer	0.000946	0.00145	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—liver cancer	0.000941	0.00145	CcSEcCtD
Lisinopril—Neuropathy peripheral—Doxorubicin—liver cancer	0.000938	0.00144	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—liver cancer	0.000933	0.00143	CcSEcCtD
Lisinopril—Rhinitis—Epirubicin—liver cancer	0.000931	0.00143	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—liver cancer	0.000931	0.00143	CcSEcCtD
Lisinopril—Hepatitis—Epirubicin—liver cancer	0.000929	0.00143	CcSEcCtD
Lisinopril—Pharyngitis—Epirubicin—liver cancer	0.000922	0.00142	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—liver cancer	0.000918	0.00141	CcSEcCtD
Lisinopril—Urinary tract disorder—Epirubicin—liver cancer	0.000917	0.00141	CcSEcCtD
Lisinopril—Oedema peripheral—Epirubicin—liver cancer	0.000915	0.00141	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—liver cancer	0.000913	0.0014	CcSEcCtD
Lisinopril—Urethral disorder—Epirubicin—liver cancer	0.000911	0.0014	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—liver cancer	0.000905	0.00139	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—liver cancer	0.000903	0.00139	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—liver cancer	0.000898	0.00138	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—liver cancer	0.000893	0.00137	CcSEcCtD
Lisinopril—Erythema multiforme—Epirubicin—liver cancer	0.000878	0.00135	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—liver cancer	0.000875	0.00134	CcSEcCtD
Lisinopril—Tinnitus—Epirubicin—liver cancer	0.000866	0.00133	CcSEcCtD
Lisinopril—Flushing—Epirubicin—liver cancer	0.000862	0.00132	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—liver cancer	0.000862	0.00132	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—liver cancer	0.000859	0.00132	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—liver cancer	0.000853	0.00131	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—liver cancer	0.000849	0.0013	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—liver cancer	0.000847	0.0013	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—liver cancer	0.000843	0.00129	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—liver cancer	0.000842	0.00129	CcSEcCtD
Lisinopril—Mediastinal disorder—Epirubicin—liver cancer	0.000837	0.00129	CcSEcCtD
Lisinopril—Chills—Epirubicin—liver cancer	0.000833	0.00128	CcSEcCtD
Lisinopril—Arrhythmia—Epirubicin—liver cancer	0.00083	0.00127	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—liver cancer	0.000821	0.00126	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—liver cancer	0.000814	0.00125	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—liver cancer	0.000813	0.00125	CcSEcCtD
Lisinopril—Erythema—Epirubicin—liver cancer	0.000809	0.00124	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—liver cancer	0.000809	0.00124	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—liver cancer	0.000801	0.00123	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—liver cancer	0.000798	0.00122	CcSEcCtD
Lisinopril—Flatulence—Epirubicin—liver cancer	0.000797	0.00122	CcSEcCtD
Lisinopril—Tension—Epirubicin—liver cancer	0.000793	0.00122	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—liver cancer	0.000792	0.00122	CcSEcCtD
Lisinopril—Nervousness—Epirubicin—liver cancer	0.000785	0.00121	CcSEcCtD
Lisinopril—Back pain—Epirubicin—liver cancer	0.000782	0.0012	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—liver cancer	0.00078	0.0012	CcSEcCtD
Lisinopril—Muscle spasms—Epirubicin—liver cancer	0.000777	0.00119	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—liver cancer	0.000775	0.00119	CcSEcCtD
Lisinopril—Chills—Doxorubicin—liver cancer	0.000771	0.00118	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—liver cancer	0.000768	0.00118	CcSEcCtD
Lisinopril—Vision blurred—Epirubicin—liver cancer	0.000762	0.00117	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—liver cancer	0.000759	0.00117	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—liver cancer	0.000753	0.00116	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—liver cancer	0.00075	0.00115	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—liver cancer	0.000748	0.00115	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—liver cancer	0.000748	0.00115	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—liver cancer	0.000747	0.00115	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—liver cancer	0.000737	0.00113	CcSEcCtD
Lisinopril—Tension—Doxorubicin—liver cancer	0.000734	0.00113	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—liver cancer	0.000733	0.00113	CcSEcCtD
Lisinopril—Malaise—Epirubicin—liver cancer	0.000729	0.00112	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—liver cancer	0.000727	0.00112	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—liver cancer	0.000726	0.00112	CcSEcCtD
Lisinopril—Syncope—Epirubicin—liver cancer	0.000725	0.00111	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—liver cancer	0.000724	0.00111	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—liver cancer	0.000724	0.00111	CcSEcCtD
Lisinopril—Nateglinide—ALB—liver cancer	0.000722	0.113	CrCbGaD
Lisinopril—Muscle spasms—Doxorubicin—liver cancer	0.000719	0.0011	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—liver cancer	0.000715	0.0011	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—liver cancer	0.000711	0.00109	CcSEcCtD
Lisinopril—Cough—Epirubicin—liver cancer	0.000706	0.00108	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—liver cancer	0.000705	0.00108	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—liver cancer	0.000694	0.00107	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—liver cancer	0.000692	0.00106	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—liver cancer	0.000688	0.00106	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—liver cancer	0.000688	0.00106	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—liver cancer	0.000688	0.00106	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—liver cancer	0.000686	0.00105	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000684	0.00105	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—liver cancer	0.00068	0.00104	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—liver cancer	0.000675	0.00104	CcSEcCtD
Lisinopril—Dry mouth—Epirubicin—liver cancer	0.000673	0.00103	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—liver cancer	0.000672	0.00103	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—liver cancer	0.000671	0.00103	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—liver cancer	0.00067	0.00103	CcSEcCtD
Lisinopril—Confusional state—Epirubicin—liver cancer	0.000665	0.00102	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—liver cancer	0.000661	0.00102	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—liver cancer	0.00066	0.00101	CcSEcCtD
Lisinopril—Oedema—Epirubicin—liver cancer	0.00066	0.00101	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—liver cancer	0.000658	0.00101	CcSEcCtD
Lisinopril—Infection—Epirubicin—liver cancer	0.000656	0.00101	CcSEcCtD
Lisinopril—Cough—Doxorubicin—liver cancer	0.000653	0.001	CcSEcCtD
Lisinopril—Shock—Epirubicin—liver cancer	0.000649	0.000997	CcSEcCtD
Lisinopril—Thrombocytopenia—Epirubicin—liver cancer	0.000646	0.000992	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—liver cancer	0.000644	0.000989	CcSEcCtD
Lisinopril—Skin disorder—Epirubicin—liver cancer	0.000641	0.000984	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—liver cancer	0.000638	0.00098	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—liver cancer	0.000637	0.000978	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—liver cancer	0.000637	0.000978	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—liver cancer	0.000637	0.000978	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—liver cancer	0.000635	0.000975	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000633	0.000971	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—liver cancer	0.000629	0.000966	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—liver cancer	0.000629	0.000966	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—liver cancer	0.000623	0.000957	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—liver cancer	0.000617	0.000947	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—liver cancer	0.000616	0.000945	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—liver cancer	0.000611	0.000938	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—liver cancer	0.000611	0.000938	CcSEcCtD
Lisinopril—Infection—Doxorubicin—liver cancer	0.000607	0.000932	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000601	0.000923	CcSEcCtD
Lisinopril—Shock—Doxorubicin—liver cancer	0.000601	0.000923	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—liver cancer	0.000598	0.000918	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—liver cancer	0.000597	0.000917	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—liver cancer	0.000596	0.000915	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—liver cancer	0.000593	0.000911	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—liver cancer	0.000593	0.00091	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—liver cancer	0.00059	0.000906	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—liver cancer	0.000588	0.000903	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—liver cancer	0.000587	0.000901	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—liver cancer	0.000582	0.000894	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—liver cancer	0.000581	0.000892	CcSEcCtD
Lisinopril—Decreased appetite—Epirubicin—liver cancer	0.000574	0.000881	CcSEcCtD
Lisinopril—Hypotension—Doxorubicin—liver cancer	0.000571	0.000876	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—liver cancer	0.00057	0.000875	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—liver cancer	0.000569	0.000874	CcSEcCtD
Lisinopril—Pain—Epirubicin—liver cancer	0.000564	0.000867	CcSEcCtD
Lisinopril—Constipation—Epirubicin—liver cancer	0.000564	0.000867	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000556	0.000854	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—liver cancer	0.000552	0.000848	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—liver cancer	0.000548	0.000842	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—liver cancer	0.000544	0.000836	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—liver cancer	0.000544	0.000835	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—liver cancer	0.000543	0.000834	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—liver cancer	0.00054	0.000829	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—liver cancer	0.000537	0.000825	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—liver cancer	0.000531	0.000815	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000527	0.00081	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—liver cancer	0.000526	0.000808	CcSEcCtD
Lisinopril—Urticaria—Epirubicin—liver cancer	0.000524	0.000805	CcSEcCtD
Lisinopril—Pain—Doxorubicin—liver cancer	0.000522	0.000802	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—liver cancer	0.000522	0.000802	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—liver cancer	0.000522	0.000801	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—liver cancer	0.000522	0.000801	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—liver cancer	0.000503	0.000773	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—liver cancer	0.000499	0.000767	CcSEcCtD
Lisinopril—Hypersensitivity—Epirubicin—liver cancer	0.000486	0.000747	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—liver cancer	0.000485	0.000745	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—liver cancer	0.000483	0.000741	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—liver cancer	0.000483	0.000741	CcSEcCtD
Lisinopril—Asthenia—Epirubicin—liver cancer	0.000473	0.000727	CcSEcCtD
Lisinopril—Pruritus—Epirubicin—liver cancer	0.000467	0.000717	CcSEcCtD
Lisinopril—Diarrhoea—Epirubicin—liver cancer	0.000452	0.000693	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—liver cancer	0.00045	0.000691	CcSEcCtD
Lisinopril—Asthenia—Doxorubicin—liver cancer	0.000438	0.000673	CcSEcCtD
Lisinopril—Dizziness—Epirubicin—liver cancer	0.000436	0.00067	CcSEcCtD
Lisinopril—Pruritus—Doxorubicin—liver cancer	0.000432	0.000663	CcSEcCtD
Lisinopril—Vomiting—Epirubicin—liver cancer	0.00042	0.000644	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—liver cancer	0.000418	0.000642	CcSEcCtD
Lisinopril—Rash—Epirubicin—liver cancer	0.000416	0.000639	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—liver cancer	0.000416	0.000638	CcSEcCtD
Lisinopril—Headache—Epirubicin—liver cancer	0.000413	0.000635	CcSEcCtD
Lisinopril—Dizziness—Doxorubicin—liver cancer	0.000404	0.00062	CcSEcCtD
Lisinopril—Nausea—Epirubicin—liver cancer	0.000392	0.000602	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—liver cancer	0.000388	0.000596	CcSEcCtD
Lisinopril—Rash—Doxorubicin—liver cancer	0.000385	0.000591	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—liver cancer	0.000385	0.000591	CcSEcCtD
Lisinopril—Headache—Doxorubicin—liver cancer	0.000383	0.000587	CcSEcCtD
Lisinopril—Nausea—Doxorubicin—liver cancer	0.000363	0.000557	CcSEcCtD
